Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals
Clinical Benefit
| Substantial |
Le service médical rendu par COSOPT 20 mg/5 ml/ml, collyre en solution en récipient unidose, est important.
|
Clinical Added Value
| no clinical added value |
COSOPT 20 mg/5 mg/ml, collyre en solution en récipient unidose, n'apporte pas d'amélioration du service médical rendu (niveau V) par rapport COSOPT, collyre en solution en flacon multidose.
|
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
TQRzTvXP7S70uSG8
